|
gptkbp:instanceOf
|
gptkb:drug
bile acid
|
|
gptkbp:ATCCode
|
A05AA02
|
|
gptkbp:CASNumber
|
128-13-2
|
|
gptkbp:category
|
gptkb:World_Health_Organization_essential_medicines
cholagogue
hepatoprotective agent
|
|
gptkbp:chemicalFormula
|
C24H40O4
|
|
gptkbp:contraindication
|
pregnancy (relative)
acute inflammation of the gallbladder
calcified gallstones
complete biliary obstruction
|
|
gptkbp:discoveredBy
|
1902
|
|
gptkbp:eliminationHalfLife
|
3.5-5.8 days
|
|
gptkbp:excretion
|
feces
|
|
gptkbp:FDAApproved
|
1997
|
|
gptkbp:foundIn
|
gptkb:bear_bile
|
|
gptkbp:has_stereochemistry
|
3α,7β-dihydroxy
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
ursodeoxycholic acid
|
|
gptkbp:IUPACName
|
gptkb:(3α,5β,7β)-3,7-dihydroxycholan-24-oic_acid
|
|
gptkbp:KEGGID
|
gptkb:D00224
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
improves bile flow
protects cholangiocytes
reduces cholesterol absorption
|
|
gptkbp:meltingPoint
|
203–204 °C
|
|
gptkbp:MeSH_ID
|
gptkb:D014522
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
392.57 g/mol
|
|
gptkbp:origin
|
isolated from bear bile
secondary bile acid
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:producedBy
|
intestinal bacteria
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1405
gptkb:DB01586
4935
4768
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
diarrhea
abdominal pain
|
|
gptkbp:solubility
|
slightly soluble in water
|
|
gptkbp:synonym
|
gptkb:ursodiol
|
|
gptkbp:UNII
|
724L30Y2RM
|
|
gptkbp:used_in
|
gptkb:traditional_medicine
|
|
gptkbp:usedFor
|
dissolution of gallstones
treatment of cholestatic liver diseases
treatment of primary biliary cholangitis
|
|
gptkbp:bfsParent
|
gptkb:Primary_Biliary_Cholangitis
|
|
gptkbp:bfsLayer
|
5
|